Coating Integrity and Acute Particulate Testing for Medical Devices
Coating Integrity and Acute Particulate Testing for Medical Devices
Coated and blood-contacting medical devices may release particulate during manufacturing, handling, delivery, deployment, retrieval, or simulated use. Particulate can originate from coatings, device materials, packaging, processing residues, or interactions between the device and delivery system.
Alta Biomed provides coating integrity inspection and acute particulate testing support for vascular and blood-contacting medical devices. Our testing programs can help device developers evaluate coating durability, identify particulate sources, compare design or process changes, and generate development-stage data to support regulatory planning.
Acute Particulate Testing
Acute particulate testing evaluates particulate that may be generated or released during device preparation, delivery, deployment, use, retrieval, or withdrawal. For vascular and blood-contacting devices, this testing is often performed using a simulated-use model that reflects the device’s intended clinical workflow.
Alta can support device-specific acute particulate testing for coated and uncoated medical devices, including test fixture development, tortuous path models, sample collection, particle counting, particle sizing, and inspection of recovered particulate.
Testing programs may be designed to support applicable ASTM, ISO, and AAMI-aligned evaluation strategies where appropriate.
Why Simulated Use Matters
Particulate generation can depend strongly on how a device is handled and used. A simple rinse or beaker extraction may not represent the mechanical challenges of device tracking, delivery, deployment, recapture, retrieval, or withdrawal.
For many vascular devices, a simulated-use model can provide more relevant information by exposing the device to conditions that better reflect clinical handling and anatomical constraints.
Simulated-use conditions may include:
Device preparation and flushing
Tracking through a tortuous path model
Delivery system interaction
Deployment or expansion
Retraction, recapture, or retrieval
Withdrawal through access components
Collection of generated particulate for counting and characterization
Coating Integrity Inspection
Coating integrity inspection evaluates whether the coating remains visually intact after manufacturing, handling, simulated use, deployment, or other relevant device challenges.
Alta evaluates coating integrity using optical microscopy and, when appropriate, scanning electron microscopy. SEM analysis can be performed in collaboration with a qualified partner laboratory to provide higher-magnification assessment and representative images of observed defects, anomalies, residues, or surface artifacts.
Coating integrity inspection may evaluate:
Coating cracks
Delamination
Flaking
Peeling
Surface artifacts
Abrasion marks
Webbing or bridging
Coating voids
Nonuniform regions
Particulate or debris on the device surface
Changes after simulated use
Devices We Test
Alta supports coating integrity and particulate testing for vascular and blood-contacting devices, including:
Stents and covered stents
Vascular grafts and stent grafts
Catheters and catheter-based devices
Delivery systems
Blood filters and embolic protection devices
Nitinol frames and implants
PET / polyester and ePTFE devices
Coated polymeric or metallic components
Other implantable or intravascular devices
Testing should be designed around the finished device, delivery system, intended use, and specific particulate risk questions.
Test Design and Study Outputs
A coating integrity or particulate testing program may include:
Device and procedure review
Identification of particulate risk points
Simulated-use model design
Tortuous path fixture selection or development
Sample preparation and device handling instructions
Particle collection method
Particle counting and sizing
Optical microscopy
SEM imaging, when appropriate
Comparison of coated vs. uncoated devices
Comparison of process or design iterations
Technical summary report with representative images
Study outputs may include particle counts by size range, representative images, observations of visible or microscopic particulate, coating integrity findings, and a written technical summary.
Coated vs. Uncoated or Process Comparison Testing
Coating and particulate testing is often most useful when used comparatively. Alta can help evaluate:
Coated vs. uncoated devices
New coating process vs. previous process
Different coating thicknesses
Different surface preparation methods
Different delivery system configurations
Design iteration A vs. design iteration B
Before and after simulated use
Prototype vs. production-intent samples
This comparative approach helps identify whether particulate or coating integrity findings are related to the coating, base device, delivery system, handling process, or test model.
Support for AAMI TIR42-Aligned Particulate Evaluation
AAMI TIR42:2021 is focused on particulate associated with vascular medical devices and is intended to help manufacturers define appropriate test methods, identify particulate sources, assess clinical risk, and establish particulate limits. FDA lists AAMI TIR42:2021 as a recognized consensus standard for medical devices.
Alta’s particulate testing programs can be designed to support AAMI TIR42-aligned development and regulatory evaluation strategies. The appropriate test method, particle collection approach, analytical method, and reporting format should be determined based on the device type, intended use, risk assessment, and applicable regulatory expectations.
Why Alta Biomed
Alta Biomed combines medical device coating expertise with practical testing support for coated and blood-contacting devices. Our team understands the challenges associated with thin-film coatings, vascular device geometries, surface characterization, simulated use, particulate risk, and coating integrity evaluation.
Alta can support early feasibility studies, coating process development, design iteration comparisons, simulated-use testing, coating inspection, acute particulate testing, and follow-on hemocompatibility evaluations.
Need to evaluate coating integrity or acute particulate generation for a coated medical device? Contact Alta Biomed to discuss simulated-use testing, tortuous path fixture development, microscopy, and particulate assessment.